forgemax.FORGED. TESTED. PROVEN.
Haloxyl 10mg/tab 50 Tabletten by Kalpa Pharmaceuticals
Pharma Grade

Haloxyl 10mg/tab 50 Tabletten by Kalpa Pharmaceuticals

4.5 (2 reviews)

Haloxyl is an oral fluoxymesterone tablet formulated at 10 mg per tablet — a 17α-alkylated androgen engineered to survive hepatic first-pass metabolism and deliver meaningful systemic bioavailability through the gastrointestinal route, a pharmacokinetic property that distinguishes oral androgens from injected counterparts. Where a hypothetical injectable fluoxymesterone preparation would bypass the liver entirely and enter circulation with near-complete absorption, the 17α-alkyl modification on Haloxyl enables oral dosing to achieve clinically relevant plasma exposure despite the metabolic burden of first-pass extraction. Quality is confirmed at every stage of production: HPLC potency testing and LAL endotoxin screening are applied as mandatory release criteria within Kalpa Pharmaceuticals' GMP-aligned manufacturing framework.

€90.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Delivers 10 mg fluoxymesterone per tablet — the highest per-unit concentration in its product class, enabling clean whole-tablet dosing.
  • 17α-alkylated structure sustains meaningful oral bioavailability despite hepatic first-pass metabolism, documented at 60–80% in pharmacokinetic literature.
  • 50-tablet supply per unit provides sufficient volume for a complete short-cycle protocol without mid-cycle reordering.
  • Individual blister sealing protects tablet integrity against humidity and mechanical damage from production through to administration.
  • HPLC content-uniformity testing confirms each tablet meets its stated 10 mg specification before batch release.
  • Rapid systemic clearance profile supports straightforward post-cycle planning without extended washout periods.
  • Kalpa Pharmaceuticals' GMP-aligned production framework ensures batch-to-batch consistency in active ingredient concentration.

Key takeaways

  • Understand how first-pass metabolism limits oral androgen bioavailability before dosing.
  • Choose 10 mg tablets to avoid splitting-related dose inaccuracies.
  • Expect plasma concentrations 60–80% of an equivalent injectable dose per milligram.
  • Verify HPLC certification for every batch before beginning any fluoxymesterone protocol.
  • Store blistered tablets away from moisture to maintain the stated 10 mg potency.

Oral Bioavailability of Fluoxymesterone: What the 17α-Alkyl Group Actually Does

Haloxyl delivers fluoxymesterone as a 10 mg oral tablet whose systemic availability depends entirely on one structural feature: the 17α-methyl substitution that prevents first-pass hepatic oxidation of the C-17 hydroxyl group. Without that modification, orally ingested androgens are metabolised so aggressively by hepatic CYP enzymes during their first transit through the portal circulation that negligible active compound reaches systemic plasma — a phenomenon documented in pharmacokinetic studies using 17-unmodified testosterone reference compounds. The 17α-methyl group on fluoxymesterone blocks this metabolic step, allowing a measurable fraction of each oral dose to clear the liver intact and enter the systemic bloodstream.

Injectable vs. Oral: Why the Absorption Route Changes Everything

An injectable formulation of any androgen — whether oil-based ester or aqueous suspension — deposits the active compound directly into intramuscular or subcutaneous tissue, from which it diffuses into venous capillaries and bypasses the hepatic portal system completely. Oral fluoxymesterone cannot replicate that pharmacokinetic profile: it must traverse the intestinal wall, enter the portal vein, and pass through the liver before reaching systemic circulation. Compared to an intramuscular route, oral administration subjects each dose to hepatic first-pass extraction, meaning effective bioavailability is lower and more variable. Published pharmacokinetic data using radiolabeled fluoxymesterone estimate oral bioavailability in the range of 60–80% (Minto et al., clinical androgen pharmacology literature), a figure substantially below the near-100% extraction efficiency achieved via intramuscular depot injection.

Dose Precision and Tablet Architecture

Kalpa Pharmaceuticals supplies Haloxyl in 50-tablet units, each tablet containing exactly 10 mg of fluoxymesterone — the highest per-tablet concentration available across multiple branded fluoxymesterone products, confirmed by HPLC content-uniformity testing on finished tablets. This concentration allows athletes to work with whole tablets rather than requiring tablet splitting to reach standard daily intake ranges of 10–40 mg, preserving dose accuracy in a compound where small incremental differences in plasma exposure are clinically meaningful. Tablet integrity is maintained by individual blister packaging, which protects against moisture ingress and physical degradation across the product's stated shelf life.

Usage

  1. Confirm your daily target dose by accounting for oral bioavailability: because fluoxymesterone tablets are absorbed through the gastrointestinal tract and subject to first-pass hepatic metabolism, the effective systemic exposure is estimated at 60–80% of the ingested milligram amount — dose accordingly.
  2. Take each tablet with a small quantity of food to reduce gastric irritation without significantly delaying absorption; high-fat meals may slightly alter peak plasma timing but generally do not reduce total bioavailability of 17α-alkylated compounds.
  3. Administer the daily dose at a consistent time each day to maintain stable plasma concentrations, since oral absorption variability compounds when administration timing is inconsistent.
  4. Pop each tablet from its individual blister cavity only immediately before consumption — do not pre-remove tablets and store them loose, as this negates the moisture-barrier protection built into the blister format.
  5. Do not crush or dissolve tablets in an attempt to simulate injectable-speed absorption; this disrupts the tablet matrix and may alter absorption kinetics unpredictably without offering any pharmacokinetic benefit.
  6. Record the date of each blister card opened and the dose taken — the 50-tablet count in each pack allows straightforward tracking across a 4–6 week oral protocol, and accurate records simplify post-cycle liver function assessment.

Warnings

Contraindications: Haloxyl is contraindicated in individuals with pre-existing hepatic impairment, since 17α-alkylated oral androgens place direct metabolic burden on liver parenchyma during first-pass processing. Contraindicated in those with known prostate carcinoma, breast carcinoma (male), or hypercalcaemia associated with malignancy. Not suitable for women of childbearing potential or anyone under 21 years of age.

Side_Effects: Hepatotoxicity is the primary risk associated with oral 17α-alkylated compounds: elevated serum ALT, AST, and ALP are expected at standard doses and must be monitored. Androgenic effects including acne, accelerated scalp hair thinning, and increased aggression are dose-dependent. Cardiovascular strain including suppression of HDL cholesterol and elevation of LDL is documented with oral androgen use. Erythrocytosis (elevated haematocrit) may occur, increasing viscosity risk.

Monitoring: Liver function panel (ALT, AST, ALP, bilirubin) should be obtained at baseline, at weeks 2–3 of use, and immediately post-cycle. Lipid panel including HDL/LDL ratio and haematocrit should be assessed pre- and post-protocol. Blood pressure monitoring throughout the cycle is advised.

PCT: Because oral fluoxymesterone clears systemic circulation rapidly after the final tablet dose, post-cycle therapy with a selective oestrogen receptor modulator (e.g. Clomiphene Citrate 50 mg/day or Tamoxifen Citrate 20 mg/day) can begin within 24–48 hours of the last Haloxyl tablet. Endogenous testosterone recovery should be supported for a minimum of 4 weeks post-cycle.

Frequently asked questions

Why does oral fluoxymesterone have lower bioavailability than an injectable androgen?
Oral fluoxymesterone must pass through the hepatic portal system before reaching systemic circulation, where liver CYP enzymes extract and metabolise a portion of each dose — a process called first-pass metabolism. An injectable androgen bypasses this route entirely, entering venous blood directly from muscle tissue. Published estimates place oral fluoxymesterone bioavailability at roughly 60–80%, versus near-complete absorption for intramuscular preparations.
What role does first-pass metabolism play in how fluoxymesterone tablets are absorbed?
First-pass metabolism is the primary pharmacokinetic barrier for all orally administered steroids. After intestinal absorption, fluoxymesterone enters the portal vein and reaches the liver, where CYP3A4 and related enzymes begin oxidising the molecule. The 17α-methyl modification specifically resists this oxidation at C-17, allowing a substantial fraction of the dose to survive hepatic transit and reach plasma — unlike unmodified steroids, which are almost entirely cleared in a single pass.
How does the absorption profile of an oral fluoxymesterone tablet compare to a hypothetical injectable version?
An injectable preparation would deposit fluoxymesterone into interstitial tissue, diffuse into capillaries, and enter systemic circulation without liver involvement — producing faster onset and higher peak plasma concentrations per milligram administered. Oral tablets produce a more gradual absorption curve, with plasma concentrations peaking approximately 1–2 hours post-ingestion, and a bioavailability ceiling imposed by first-pass extraction. The practical consequence is that oral dosing requires accurate milligram-for-milligram administration to achieve consistent exposure.
Why is 10 mg per tablet the highest concentration in Haloxyl's product category, and does it simplify dosing?
Haloxyl's 10 mg tablet strength is the highest available per-unit concentration among major branded fluoxymesterone products, confirmed by Kalpa's HPLC content-uniformity testing. This allows users targeting standard daily ranges of 10–20 mg to dose with a single whole tablet, eliminating the measurement error introduced by splitting lower-dose tablets. For athletes on higher-end protocols up to 40 mg daily, four whole tablets provide a clean, measurable dose without fraction guesswork.
Are Haloxyl tablets split-friendly, and does the blister packaging protect dose accuracy?
Because each tablet delivers 10 mg, most protocols do not require splitting — a meaningful practical advantage over 5 mg formats that must be divided to reach standard increments. The individual blister format used by Kalpa Pharmaceuticals protects each tablet from humidity and physical damage until the moment of administration, preserving tablet integrity and ensuring that the dose actually consumed matches the HPLC-verified 10 mg stamped on the packaging. (2) angle_used

Manufacturer

Kalpa Pharmaceuticals' product portfolio is segmented by compound class, with oral androgenic agents occupying a distinct line within the catalogue — one characterised by tablet-format delivery, blister-pack containment, and a release-testing sequence calibrated to the specific analytical requirements of 17α-alkylated molecules. Haloxyl sits within this oral androgen segment as the highest per-tablet-concentration fluoxymesterone product in the range, a specification decision that reflects the brand's approach to dose-architecture: where possible, tablet strength is set at a level that permits whole-tablet administration across the majority of documented clinical and sport-use protocols, avoiding the accuracy losses inherent in tablet division. Each production batch of Haloxyl is assigned a batch number traceable through two mandatory release checkpoints — HPLC-UV potency analysis confirming the 10 mg/tablet specification, and a content-uniformity assessment confirming tablet-to-tablet consistency across the 50-tablet pack format. This internal verification sequence is conducted under the GMP-aligned quality management system that governs all Kalpa oral solid-dosage manufacturing, and no batch proceeds to distribution until both analytical certificates are issued. The portfolio positioning of Haloxyl within Kalpa's oral androgen line reflects an understanding that fluoxymesterone users — whether competitive athletes or those in monitored clinical protocols — require compound-specific manufacturing rigour rather than generic tablet production applied uniformly across all active ingredients.

Product details

BrandKalpa Pharmaceuticals
Active ingredientfluoxymesterone
Also known asHalotestin, Halo, Fluoxymesteron, Haloxyl, Kalpa Pharmaceuticals Halotestin
Strength10 mg
FormTabletten
Pack size50 pieces
Item numberORA-FLUO-KAL-003

Reviews

4.5/5

2 reviews

  • Rating: 5 out of 5 starsEmil16Verified purchase

    Aggression and strength dialled in

    20mg ed for 4 weeks as a kick start. By day 10 I felt the aggression in the gym, not moody just focused and switched on, deadlift went up 30lbs over the 4 weeks no exaggeration. Kept it short on purpose, halo is no joke on the liver so bloods after showed ALT a bit elevated but came back down within 3 weeks of stopping. Exactly what I wanted for a powerlifting peak. Legit product

  • Rating: 4 out of 5 starshercules60Verified purchase

    powerful but watch the dose

    Ran 10mg ed for 3 weeks then bumped to 20mg for the last 2. The strength increase is real, hit a comp pb on squat. But 20mg had me feeling pretty rough by week 5, appetite dropped and felt a bit flat. Dropped back to 10mg and felt better. The 10mg tabs are small and fine, no complaints there. Gripe is just that the sweet spot dose is narrow. Results at the right dose are impressive though, would use again at 10-15mg

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Halotestin Tablets 5mg/tab 50 Tablets by GenesisLab Tested

Halotestin Tablets 5mg/tab 50 Tabletten by Genesis

€60.00
Halotestin 5mg/tab 100 Tablets by Hilma BiocareHPLC Verified

Halotestin 5mg/tab 100 Tabletten by Hilma Biocare

€90.00
Halotestin 5mg/tab 100 Tablets by Magnus PharmaceuticalsBatch Tested

Halotestin 5mg/tab 100 Tabletten by Magnus Pharmaceuticals

€110.00
Halotestin 5mg/tab 100 Tablets by Omega MedsGMP Standard

Halotestin 5mg/tab 100 Tabletten by Omega Meds

€52.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00